Supply Chain

Though texting prescription orders has become common in many organizations, a new survey from the Institute for Safe Medication Practices found 33 percent of hospital workers oppose the practice, according to Pharmacy Practice News.

Atenolol, a beta blocker used to treat high blood pressure, chest pain and heart attacks, has been in short supply since July.

Here are six articles Becker's Hospital Review published in the last week, featuring a look at the Drug Enforcement Agency's mandate to decrease opioid production by 20 percent in 2018 and CVS Health's "real-time benefits" tool to boost drug price transparency.

The FDA recently cleared AliveCor's electrocardiogram accessory for the Apple Watch, the Mountain View, Calif.-based company announced Nov. 30.

About 10 percent of medical products in the world's poorest countries are either counterfeits or do not meet quality requirements, according to research from the World Health Organization.

The FDA is warning healthcare providers, laboratory personnel, lab test developers and the public that biotin, vitamin B7, may interfere with laboratory tests and cause incorrect test results.

Gilead Sciences, a biopharmaceutical company based in Foster City, Calif., launched its hepatitis C drug in China with a price tag significantly lower than in the U.S., according to Caixin Global.

CVS Health's pharmacy benefits manager CVS Caremark, launched its "real-time benefits" tool to increase price transparency across all points of care.

How a structured assessment can help you identify supply chain improvement opportunities

Hospitals markup brand-name drugs nearly 487 percent, according to a study performed by The Moran Company and commissioned by Pharmaceutical Research and Manufacturers of America.